Novartis Rally Seen on Key U.S. Drug Approval
March 06, 2007 | The U.S. Food and Drug Administration approved the once-daily oral tablet Tekturna, Novartis said on Tuesday. It was developed with Swiss drug firm Speedel, as the first in a new class of drugs called direct renin inhibitors. Story in Reuters.
Feeds